First AI Device for Colonoscopy: Extra Set of Expert ‘Eyes’

The first artificial intelligence (AI) endoscopy module developed specifically to help detect adenomas during routine colonoscopy is making its debut…

White Bagging: Insurer Shift on Drugs Raises Alarm

A big change in drug treatment for cancer is arriving in Georgia. It’s not a new medication. What’s coming is something…

Adverse Reactions to Immunotherapy Can Appear After a Year

Clinicians should be on the lookout for immune-related adverse reactions (irAEs) even after patients have been receiving anti–programmed cell death…

Genetic Testing for Breast and Ovarian Cancer

A large, retrospective study shows how germline genetic testing has evolved over time in women with breast or ovarian cancer…

Nivolumab-Cabozantinib Boosts Survival in Kidney Cancer

NEW YORK (Reuters Health) – Previously untreated patients with advanced renal-cell carcinoma live twice as long without disease progression when…

Vir, GSK to Halt Enrollment in US COVID-19 Antibody Trial Substudy

Vir Biotechnology and Britain’s GSK said on Wednesday they would pause enrollment into a study testing their experimental COVID-19 antibody…

Remission of Hodgkin Lymphoma After COVID-19

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Patients with cancer are considered at…

Adjuvant Nivolumab: A New Standard of Care in High-risk MIUC?

The checkpoint inhibitor nivolumab is efficacious and well tolerated when used as adjuvant therapy in patients who have undergone radical…